Detalhe da pesquisa
1.
Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.
Mov Disord
; 32(6): 893-903, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370447
2.
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
Headache
; 57(6): 862-876, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28497569
3.
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
BMC Neurol
; 16: 89, 2016 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276999
4.
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
CNS Spectr
; 21(6): 450-459, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26471212
5.
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Headache
; 55(5): 621-35, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25941016
6.
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
JAMA
; 314(12): 1242-54, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26393847
7.
Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.
J Neurooncol
; 118(1): 93-100, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24700239
8.
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
Alzheimers Dement
; 10(5): 571-81, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24411134
9.
Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Neurobiol Dis
; 44(1): 38-52, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21704161
10.
Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
Mov Disord
; 26(1): 27-36, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21322017
11.
Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
BMC Neurol
; 16(1): 160, 2016 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27590297
12.
Dextromethorphan-Quinidine for Agitation in Alzheimer Disease--Reply.
JAMA
; 315(11): 1166-7, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26978215
13.
Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial.
PM R
; 2018 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29964212
14.
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.
JAMA Neurol
; 75(7): 834-841, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29582053
15.
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use.
Pharmacol Ther
; 164: 170-82, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27139517
16.
Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors.
Neuro Oncol
; 4(4): 253-60, 2002 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12356355
17.
Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.
Neuro Oncol
; 5(3): 188-96, 2003 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-12816725
18.
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients.
Neurology
; 80(18): 1698-701, 2013 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23576625
19.
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
Lancet Neurol
; 9(12): 1164-1172, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20970382